Invesco Biotechnology & Genome ETF
PBE
PBE
101 hedge funds and large institutions have $80.3M invested in Invesco Biotechnology & Genome ETF in 2023 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 18 increasing their positions, 26 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
31% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 26
Holders
101
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.33M | |
| 2 | +$931K | |
| 3 | +$801K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$418K |
| 5 |
SFM
Signet Financial Management
Parsippany,
New Jersey
|
+$315K |
Top Sellers
| 1 | -$336K | |
| 2 | -$314K | |
| 3 | -$236K | |
| 4 |
CMS
Capital Market Strategies
Palm Beach Gardens,
Florida
|
-$233K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$208K |